Zealand University Hospital, Roskilde | Clinical Research Unit

Research site
Vestermarksvej 9, 3. sal., Roskilde, Sjælland, Denmark
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


2 of 7
Status: Active
Trial type: Interventional
Funder type: Industry

A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) (EPCORE DLBCL-2)

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). The purpose of t...

Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab
Drug: Rituximab

This is a Phase 3, randomized, parallel-group, comparator-controlled, observer-blind, multicenter study of immunogenicity and safety in approximately...

Active, not recruiting
Influenza, Human
Biological: licensed QIV1
Biological: licensed QIV2

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems